Quest Diagnostics Divests OralDNA Labs | GenomeWeb

NEW YORK (GenomeWeb News) – Quest Diagnostics today said that it has sold substantially all of the assets of its OralDNA Labs business to Access Genetics for an undisclosed sum.

The business, which currently provides saliva-based testing from a facility in Tennessee, will be consolidated with Access Genetics' CLIA- and CAP-certified lab in Eden Prairie, Minn. Quest noted that Access Genetics has provided support and expertise for OralDNA-based testing services for dental professionals since 2008.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.